ICAP
EPZM

Independence Capital Asset Partners’s Epizyme, Inc EPZM Stock Holding History

Independence Capital Asset Partners’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-83,335
Closed -$2.34M – 119
2013
Q2 		$2.34M Buy
+83,335
New +$2.14M 0.41% 60

Other funds holding EPZM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Independence Capital Asset Partners's EPZM Position: Q3 2013 in Review

Independence Capital Asset Partners sold out of Epizyme, Inc (EPZM) in Q3 2013, closing a stake of 83,335 shares — an estimated $2.34M sold.

Independence Capital Asset Partners first reported a position in EPZM in Q2 2013 and held it in 1 quarter. The position peaked at $2.34M in Q2 2013. 67 funds tracked by Wall St. Rank hold EPZM as of Q3 2013.

  • Independence Capital Asset Partners reported no remaining Epizyme, Inc position as of Q3 2013 after selling out during the quarter.
  • Independence Capital Asset Partners sold 83,335 Epizyme, Inc shares in Q3 2013, an estimated $2.34M.
  • Independence Capital Asset Partners first reported a position in Epizyme, Inc in Q2 2013 and held it in 1 quarter.
  • Independence Capital Asset Partners's Epizyme, Inc position peaked at $2.34M in Q2 2013.
  • 67 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2013.

Based on Independence Capital Asset Partners's 13F filing for Q3 2013, filed 14 Nov 2013.